Prise en charge de la splénomégalie chez les patients atteints de myélofibrose : quelles options en 2020 ? (notice n° 659491)
[ vue normale ]
000 -LEADER | |
---|---|
fixed length control field | 00558cam a2200157 4500500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250121191920.0 |
041 ## - LANGUAGE CODE | |
Language code of text/sound track or separate title | fre |
042 ## - AUTHENTICATION CODE | |
Authentication code | dc |
100 10 - MAIN ENTRY--PERSONAL NAME | |
Personal name | Nsiala, Laly |
Relator term | author |
245 00 - TITLE STATEMENT | |
Title | Prise en charge de la splénomégalie chez les patients atteints de myélofibrose : quelles options en 2020 ? |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Date of publication, distribution, etc. | 2020.<br/> |
500 ## - GENERAL NOTE | |
General note | 26 |
700 10 - ADDED ENTRY--PERSONAL NAME | |
Personal name | Torregrosa-Diaz |
Relator term | author |
786 0# - DATA SOURCE ENTRY | |
Note | Hématologie | 26 | 5 | 2020-09-01 | p. 225-228 | 1264-7527 |
856 41 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://shs.cairn.info/revue-hematologie-2020-5-page-225?lang=fr&redirect-ssocas=7080">https://shs.cairn.info/revue-hematologie-2020-5-page-225?lang=fr&redirect-ssocas=7080</a> |
Pas d'exemplaire disponible.
Réseaux sociaux